NYSE · HTGC

Hercules Capital, Inc.

$15.79 +$0.06 (+0.38%) 1D After hours
Session Pulse After hours 1 mentions on Fri No new SEC filings since Tue close Full pulse →

Key Metrics

$2.94B
Market cap
8.87×
P/E · TTM
Revenue · TTM
$331.90M
Net income
EPS · TTM $1.89
Dividend yield 11.3%
Free cash flow −$434.34M
Beta · 1Y 0.64
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    A material event was filed (Form 8-K).

    8-K - Hercules Capital, Inc. (0001280784) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 21
    A material event was filed (Form 8-K).

    8-K - Hercules Capital, Inc. (0001280784) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 27
    From its Jan 30 high, the share price fell 25%.

    Peak close $18.53 on Jan 30; trough close $13.89 on Mar 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -25%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.94B
Enterprise value$5.44B
Shares outstanding187.1M
52-wk range$13.70 – $19.67
Avg volume · 20D1.1M
Net cash −$2.50B
Book value / share$12.70
ExchangeNYSE
About Hercules Capital, Inc.
IPO dateJun 9, 2005
Employees50

Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E8.87
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №$23.25

Profitability

Gross
Operating
Net
FCF
ROE / ROIC 15.7% · —

Financial Health

Current ratio
Quick ratio
Debt / equity1.14
Debt / EBITDA
Net cash −$2.50B
Working capital

Cash Flow · TTM

Operating CF −$434.24M
Capex −$100.00K
Free cash flow −$434.34M
Buybacks $6.39M
Dividends paid $331.53M
Shareholder yield 11.5%

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$23.25 vs $15.79
Trades below classic defensive value — Graham-cheap
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings